spores should permit intraprocedural guidance to optimize and confirm targeted intratumoral delivery in patients with visceral organ tumors.
The innate and/or adaptive resistance of many types of cancer cells has limited tumor response to a broad range of different therapeutic options [1] including both radiation and chemotherapies. Recently, bacteriolytic therapy with anaerobic spores has received a great deal of attention given the generally favorable toxicity profile and strong oncolytic impact with minimal tumor resistance, particularly within hypoxic tissues. [2] The first use of bacterial cancer therapy was reported by William Coley 100 years ago; since that time, significant progress has been made to improve therapeutic efficacy with the advancement of recombinant DNA technology. [3] More recently, Vogelstein and co-workers demonstrated that the spore-forming obligate anaerobe Clostridium novyi (specifically C. novyi-NT, an attenuated clone derived from C. novyi after elimination of its lethal toxin [2] ) can serve as a potent therapeutic agent for the treatment of solid tumors refractory to conventional therapeutic approaches. [4] Bacteriolytic therapy using C. novyi-NT spores is currently undergoing clinical evaluation in a human phase I trial for patients with treatment-refractory tumors (NCT01924689). [3, 5] The efficacy of bacteriolytic therapy with C. novyi-NT spores has been demonstrated for a broad range of tumor etiologies, using either systemic administration approaches or percutaneous intratumoral injection. [3, 6] Intratumoral injection affords several advantages including (a) the ability to increase the number of spores that ultimately reach the targeted tumor(s) and (b) the potential to reduce systemic exposure thus limiting side-effect toxicities. Prior percutaneous protocols have involved digital palpation of surface tumors to guide injection catheter placement and/or ultrasound guidance without a means to immediately visualize spore deposition within the targeted tumors following administration. [5] X-ray CT is widely used in interventional radiology settings to guide the placement of biopsy needles and ablation electrodes during the diagnosis and treatment of solid tumors within visceral organs. CT guidance approaches should be ideal for intraprocedural optimization of injection catheter placement during bacteriolytic therapy; however, native C. novyi-NT spores are not sufficiently radio-opaque to permit in vivo visualization. Ultimately, visual confirmation of spore delivery to the tumor(s) may be critical for patient-specific Bacteriolytic therapy using the anaerobic bacterium Clostridium novyi-NT (C. novyi-NT) is considered a promising approach for the treatment of solid tumors. Imageguided intratumoral administration of C. novyi-NT spores may serve to improve therapeutic efficacy while potentially reducing toxicity (compared to systemic administration approaches). To this end, we demonstrate an approach to label C. novyi-NT spores with branched gold nanoparticles (BGNP) thus permitting intraprocedural X-ray computed tomography (CT) visualization of spore delivery to solid tumors upon intratumoral injection. BGNP-coated C. novyi-NT spores were prepared using a simple electrostatic deposition method. In PC3 prostate tumor-bearing mouse model, BGNP-coated spores were injected into the hypoxic center of each tumor with CT confirmation of intratumoral delivery. Follow-up immunohistochemical analyses were used to validate the bacteriolytic efficacy of these BGNP-coated C. novyi-NT spores in the same animal model. BGNP-coating had no impact upon spore germination and proliferation rates and in vivo results demonstrated significant bacteriolytic antitumor efficacy. Importantly these BGNP-coated procedural optimization and/or early prediction of therapeutic outcomes. [7] To this end, we have developed an approach to coat C. novyi-NT spores with BGNP for X-ray CT-guided bacteriolytic therapy. CT approaches offer unlimited penetration depth, high spatial resolution, and multiplanar reconstruction for 3D visualization. [8] Gold nanoparticles (GNP) have a high X-ray attenuation coefficient given high atomic number and electron density (z = 79, q = 19.3 g cm −3 ); [9] GNP have been considered an ideal CT contrast agent given well-established biocompatibility. In recent studies, [10] exogenous cell labeling with GNP permitted CT imaging of cell migration and examination of resulting biodistribution. Recently, our group developed a unique deoxycholate bile acid directed method for efficient, biocompatible synthesis of BGNP. [11] BGNP are particularly promising CT contrast agents given the large relative surface (compared to spherical GNP) that can yield strong X-ray attenuation characteristics. For our studies (Scheme 1a), the peptidoglycan walls of C. novyi-NT spores were electrostatically coated with functionalized BGNP. Following in vitro characterization studies, our BGNP-coated C. novyi-NT spores were injected into mouse PC-3 tumors (prostate cancer xenograft model) to validate the potential for noninvasive CT visualization and confirm bacteriolytic efficacy with comparison to PC-3 tumors treated with native (uncoated) spores.
C. novyi-NT spores were isolated by use of a Percoll density gradient column (see the Supporting Information, Figure S1 ) [12] prior to the following studies. To prepare the BGNP-coated C. novyi-NT spores, an electrostatic deposition method (Scheme 1b) was adopted. Electrostatic deposition is commonly used for cell-surface engineering given facile nature of the procedure, efficient synthetic yield, and relatively minimal observed toxicities. [13] The surface of C. novyi-NT spores is negatively charged due to the N-acetylmuramic acid moieties on the peptidoglycan membrane. [14] The negatively charged C. novyi-NT spores were functionalized with positively charged small-molecular-weight branched polyethylenimine (bPEI, 600 Da) to avoid the undesirable cytotoxicity observed with high-molecular-weight bPEI. [15] After cationic bPEI polymer functionalization, the surface charge of C. novyi-NT spores was significantly increased from negative (≈−26 mV) to positive (≈+38 mV) ( Figure 1a) . Next, BGNP were synthesized according to our previous reported protocol through a deoxycholate bile acid directed mechanism. [11] As shown in Figure 1b , highly branched GNP were successfully synthesized and their characteristic absorption band observed across a broad range of visible and near infrared (NIR) wavelengths. These results were consistent with our previous report. [11] To confirm the superior radio-opaque characteristics of our BGNP, CT numbers (Hounsfield units, HU) were measured for phantoms produced using increasing, matched concentrations of spherical GNP and our BGNP; latter measurements were performed using a preclinical micro CT system (Mediso NanoPET/CT, see the Supporting Information, Figure S2 ). BGNP demonstrated significantly higher CT numbers than spherical GNP at concentrations above 6 mg mL −1 . This result may be attributed to the branch-shaped geometry of BGNP which results in a greater surface area than spherical counterpart of equivalent size. [16] Next, the surface charge of the BGNP needed to be modified to complex with the positively functionalized C. novyi-NT spores; thus, the synthesized BGNP were modified with 4-mercaptobenzoic acid (4-MCBA) via ligand exchange and ionization. [17] After ligand exchange with 4-MCBA, the BGNP exhibited highly negative surface charge, ≈−37 mV (Figure 1a) . Finally, the synthesized negatively charged BGNP were deposited on the positively charged spore-walls through electrostatic interaction. As shown in Figure 1a , the BGNP-coated C. novyi-NT spores exhibited negative surface charge attributable to the immobilization of the negative charged BGNP on the surface of the spores. To optimize labeling efficiency, a certain amount of C. novyi-NT spores (3.89 × 10 8 spores) was labeled with various concentrations (0.08-1.32 mg mL −1 ) of BGNP. As a result, the highest BGNP-labeling efficacy (≈91%) was www.small-journal.com achieved when 0.66 mg mL −1 of BGNP was added in C. novyi-NT spores (3.89 × 10 8 spores) ("BGNP-labeled spores 4" in Table S1 , Supporting Information). The optimized labeling condition was selected for further study. Additionally, UV-vis absorption spectra after BGNP immobilization was measured to observe optical property changes (Figure 1b) . NIR absorption for BGNP-coated C. novyi-NT was observed within the spectral absorption region which was the same trend that was observed for the BGNP alone. The slight absorption increase between 400 to 700 nm may be due to light absorption of the native spore itself. To investigate morphological changes after BGNP deposition, we performed scanning electronic microscopy (SEM). While native C. novyi-NT spores have a smooth spore wall structure (Figure 1d ), BGNP deposition upon the spore walls was observed for the coated C. novyi-NT spores (Figure 1e) . The germination and proliferation of C. novyi-NT spores were not affected by bPEI polymer functionalization and BGNP deposition (see the Supporting Information, Figure S3 ). To demonstrate CT contrast effects of the BGNP-coated spores, an in vitro CT phantom study was performed after BGNP labeling (Figure 1f ). While no CT contrast signal was observed in the control group (e.g., spores only, and water), in the BGNP-coated spore group significantly enhanced CT contrast was observed, which suggested the feasibility of using CT imaging to monitor in vivo delivery of our BGNP-coated spores. Overall, in vitro results indicated that BGNP coating of the C. novyi-NT spore wall was successfully achieved through electrostatic deposition. To the best of our knowledge, this is the first demonstration of GNP-coating of C. novyi-NT spores for CT image-guided bacteriolytic therapy.
To evaluate in vivo imaging capabilities and therapeutic efficacy of BGNP-coated C. novyi-NT spores, we used a human prostate cancer cell (PC3) xenograft mouse model. Because a common therapeutic option for prostate cancer is localized intervention, [18] we selected prostate cancer to assess feasibility for our CT image-guided bacteriolytic therapy. PC3 human prostate xenograft tumors were generated by inoculating PC3 human prostate cancer cells into BALB/c nude mice. BGNP-coated C. novyi-NT spores were infused via percutaneous intratumoral injection in this PC3 mouse model (dose of spores was 3 × 10 8 per mice). Precise injection of spores into solid tumors may be critical to achieve efficient germination of the C. novyi-NT anaerobes within the targeted hypoxic tissue regions. [5] We performed CT image-guided injections of the BGNP-coated C. novyi-NT spores into the center of each tumor at position anticipated to be hypoxic and necrotic. Before positioning the radio-opaque injection catheter, we could readily observe the location of the PC3 tumor on right flank within the CT images (Figure 2a, preinsertion) . Then, the injection catheter was inserted and position was adjusted such that the tip was located at the center of tumor (Figure 2a,  postinsertion) . As shown in Figure 2b , the needle-catheter position can be readily observed within the CT images. The BGNP-coated C. novyi-NT spores were then infused and the injection catheter removed. Spore deposition was observed as a punctate region of hyperattenuation within the center of each tumor, visible within both 2D axial images 3D renderings of the tumor volume (Figure 2c) . The mean region of interest (ROI) value of the injected site was ≈505 (SD, ±298). These results indicate that CT methods should permit precise image-guided delivery of BGNP-coated spores to targeted lesions. CT guidance offers tremendous advantages over optical and magnetic resonance imaging methods providing complementary anatomic information (tumor location and size) while also permitting rapid image acquisition rates, particularly well-suited for real-time procedural guidance. [9, 19] Finally, the therapeutic efficacy of BGNP-coated C. novyi-NT spores was evaluated with histological staining of tumor tissues harvested at 48 h after infusion. Germination of C. novyi-NT bacteria in tumor tissues was confirmed with gram-positive staining (Figure 3a) . Vegetative forms of C. novyi-NT were observed in both tumors treated with native C. novyi-NT as well as tumor treated with BGNPcoated C. novyi-NT spores. This result indicates that the germination capability of C. novyi-NT was not affected by BGNP deposition on spore walls, which is consistent with the in vitro germination study (see the Supporting Information, Figure S3 ). Furthermore, hematoxylin and eosin (H&E) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining analysis were performed to evaluate liquefaction (oncolysis) induced therapeutic effects within the tumor tissues (Figure 3b,c) . H&E-stained tumor tissues demonstrated a significantly increased number of necrotic tumor cells in both tumors treated with native spores and BGNP-coated spores. For quantitative immunohistochemistry analyses (Figure 3c ), TUNEL positive tumor cells were also much increased in both spore treated groups, regardless of BGNP coating. Few TUNEL positive cells were observed in nontreated control group tumors. These results indicate that BGNP-coated C. novyi-NT spores were able to retain innate antitumoral efficacy, most likely through direct oncolytic effects, [20] regardless of BGNP incorporation. However, we observed that the therapeutic effect of both native C. novyi-NT spores and BGNP-coated C. novyi-NT spores was limited to hypoxic central regions of the tumors as C. novyi-NT can survive only in hypoxic condition (see the Supporting Information, Figure S4 ). The vascularized rim of solid tumors has been well established as a major cause of tumor resistance to bacteriolytic therapy with anaerobic spores. [4, 21] To overcome this www. 21] Our approach using BGNP-coated spores could potentiate the development of salient alternative combinations. BGNP can serve as potent radiosensitizers and/or serve as highly efficient transducers for photothermal therapy. Additionally, the BGNP coating could serve as a functional carrier for concurrent intratumoral delivery of cytotoxic drugs. Regarding long-term toxicity, although clinical signs of toxicities including lethargy, weight loss, and abscessation were manageable by administration of antibiotics, [3] [4] [5] long-term risk for mutagenesis of C. novyi-NT should be evaluated in the future study.
In conclusion, in this study, we have demonstrated a new type of BGNP-coated C. novyi-NT spore for efficient CTimage guided bacteriolytic tumor therapy. BGNP-coated C. novyi-NT spores were successfully prepared with electrostatic deposition methods. In a PC3 human prostate tumor xenograft mouse model, the BGNP-coated spores were injected into a tumor site under CT image guidance. The infused BGNP-coated spores exhibited strong therapeutic efficacy consistent with that observed for native C. novyi-NT spores suggesting that the innate antitumoral function was preserved. Based on these results, we believe that our BGNP-coated C. novyi-NT spores have the potential to not only facilitate CT image-guided bacteriolytic procedures but also to serve as a novel delivery platform for a combinational tumor therapy. 
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